The protein transition from animal towards plant proteins, is driven by the growth of the world’s population combined with a rising standard of living. Over the last five years, this has already resulted in a 7-fold increase in product launches with a plant-based claim or notification. This manuscript gives an overview of current, emerging and future protein sources and their use to replace protein in dairy and meat products as well as egg proteins. Currently, a major focus is on the development of products that mimic the original product the most, for example the best meat alternative. However, the question arises if this is enough to change the overall balance between animal and plant proteins? The outlook discusses the demand for a better understanding of consumer needs and preferences.
LINK
INTRODUCTION: Sufficient high quality dietary protein intake is required to prevent or treat sarcopenia in elderly people. Therefore, the intake of specific protein sources as well as their timing of intake are important to improve dietary protein intake in elderly people.OBJECTIVES: to assess the consumption of protein sources as well as the distribution of protein sources over the day in community-dwelling, frail and institutionalized elderly people.METHODS: Habitual dietary intake was evaluated using 2- and 3-day food records collected from various studies involving 739 community-dwelling, 321 frail and 219 institutionalized elderly people.RESULTS: Daily protein intake averaged 71 ± 18 g/day in community-dwelling, 71 ± 20 g/day in frail and 58 ± 16 g/day in institutionalized elderly people and accounted for 16% ± 3%, 16% ± 3% and 17% ± 3% of their energy intake, respectively. Dietary protein intake ranged from 10 to 12 g at breakfast, 15 to 23 g at lunch and 24 to 31 g at dinner contributing together over 80% of daily protein intake. The majority of dietary protein consumed originated from animal sources (≥60%) with meat and dairy as dominant sources. Thus, 40% of the protein intake in community-dwelling, 37% in frail and 29% in institutionalized elderly originated from plant based protein sources with bread as the principle source. Plant based proteins contributed for >50% of protein intake at breakfast and between 34% and 37% at lunch, with bread as the main source. During dinner, >70% of the protein intake originated from animal protein, with meat as the dominant source.CONCLUSION: Daily protein intake in these older populations is mainly (>80%) provided by the three main meals, with most protein consumed during dinner. More than 60% of daily protein intake consumed is of animal origin, with plant based protein sources representing nearly 40% of total protein consumed. During dinner, >70% of the protein intake originated from animal protein, while during breakfast and lunch a large proportion of protein is derived from plant based protein sources.
Whether going fully vegan or embracing a more ‘flexitarian’ lifestyle, consumers are switching to plantbased food options in ever-increasing numbers. With 9 billion people to feed in the world in 2050, there are many reasons why: from perceived benefits for people’s own health and wellbeing, to concerns about animal welfare and the environmental impact of meat farming, or just the desire to be ‘on trend’.Interview with Fred van de Velde, professor and researcher at HAS University of Applied Science.
LINK
Micro and macro algae are a rich source of lipids, proteins and carbohydrates, but also of secondary metabolites like phytosterols. Phytosterols have important health effects such as prevention of cardiovascular diseases. Global phytosterol market size was estimated at USD 709.7 million in 2019 and is expected to grow with a CAGR of 8.7% until 2027. Growing adoption of healthy lifestyle has bolstered demand for nutraceutical products. This is expected to be a major factor driving demand for phytosterols. Residues from algae are found in algae farming and processing, are found as beachings and are pruning residues from underwater Giant Kelp forests. Large amounts of brown seaweed beaches in the province of Zeeland and are discarded as waste. Pruning residues from Giant Kelp Forests harvests for the Namibian coast provide large amounts of biomass. ALGOL project considers all these biomass residues as raw material for added value creation. The ALGOL feasibility project will develop and evaluate green technologies for phytosterol extraction from algae biomass in a biocascading approach. Fucosterol is chosen because of its high added value, whereas lipids, protein and carbohydrates are lower in value and will hence be evaluated in follow-up projects. ALGOL will develop subcritical water, supercritical CO2 with modifiers and ethanol extraction technologies and compare these with conventional petroleum-based extractions and asses its technical, economic and environmental feasibility. Prototype nutraceutical/cosmeceutical products will be developed to demonstrate possible applications with fucosterol. A network of Dutch and African partners will supply micro and macro algae biomass, evaluate developed technologies and will prototype products with it, which are relevant to their own business interests. ALGOL project will create added value by taking a biocascading approach where first high-interest components are processed into high added value products as nutraceutical or cosmeceutical.
The global market for the industrial manufacturing of recombinant proteins (RPS) is steadily increasing and demand will keep rising in years to come. Currently, RPs are already an integral part of disease therapeutics, agriculture and the chemical industry and RP manufacturing methods rely heavily on host systems such as prokaryotes and, to a lesser extent, mammalian, yeast and plant cells. When comparing these host systems, all have their specific strengths and weaknesses and numerous challenges remain to improve protein manufacturing on an industrial scale. In this project, GLO Biotics proposes an innovative plant-based RP expression platform with the potential of significantly reducing costs and process requirements compared to the current state-of-the-art systems. Specifically, this novel concept is based on the use of coconut water as a natural, cell-free ‘protein production factory’. Coconut water in nuts aged 4-6 months is composed of free-floating cell nuclei devoid of cell walls, and it has been demonstrated these nuclei can express foreign proteins. Compared to existing platforms, the relative ease of delivering foreign protein-coding genes into this system, as well as the ease of recovery of the produced protein, potentially offers an innovative platform with great commercial attractiveness. In summary, the aim of this project is to provide a proof-of-concept for coconut water as a novel and competitive RP production platform by demonstrating the production and recovery of several commercially available RPs. To this end, GLO Biotics intends to collaborate with Zuyd University of Applied Sciences (Zuyd) and the Aachen Maastricht Institute for Biobased Materials (AMIBM) in demonstrating the potential of the ‘GLO-Conuts’ expression system. As a consortium, Zuyd and GLO Biotics will utilize their shared experience in molecular engineering and DNA vector technology and AMIBM will bring their expertise in plant-based RP production and recovery.
Voor een efficiënte opfok van vleeskuikens, met behoud van gezondheid van mens en dier, moet aan de dieren een kwalitatief voer met daarin een hoogwaardige eiwitbron worden verstrekt. Om aan de vraag naar eiwit te voldoen, gebruikt men in de veevoederindustrie doorgaans soja. Sojaproductie gaat echter gepaard met een grote ecologische voetafdruk en de vraag naar meer duurzaam geproduceerde eiwitbronnen neemt toe. De meeste eiwitbronnen hebben echter een eiwitverteerbaarheid die lager is dan soja. Bij gebruik van deze bronnen vindt daardoor meer microbiële afbraak (eiwitfermentatie) in de dikke darm en blinde darmen plaats, wat resulteert in darmschade t.g.v. giftige afbraakproducten en bacteriële groei van Clostridium perfringens. Groei van Campylobacter spp. leidt tevens tot gezondheidsrisico voor de consument. Naast een duurzaam productieproces, moeten eiwitbronnen daarom ook een hoge eiwitverteerbaarheid hebben. Uit gesprekken die gevoerd zijn door onderzoekers van de HAS hogeschool met nutritionisten van Agrifirm, het Feed Design Lab (FDL) en leveranciers van eiwitbronnen en voederadditieven, blijkt de noodzaak tot investering in duurzame eiwitbronnen. Hiermee voldoet de veevoederindustrie ook in de toekomst aan de vraag naar hoogwaardige grondstoffen, die door vleeskuikensector, de consument en de maatschappij wordt gesteld. Kansrijke eiwitbronnen worden beoordeeld door bestaande kennis m.b.t. duurzaamheid van het productieproces te centraliseren en in-vitro verteerbaarheidsonderzoek uit te voeren. In dit project werken HAS hogeschool, Wageningen Universiteit (WUR), Agrifirm en FDL samen in een consortium. In een eerste werkpakket leidt literatuuronderzoek tot een selectie van kansrijke duurzame eiwitbronnen. In een tweede werkpakket wordt middels een Boisson-analyse de verteerbaarheid van deze eiwitbronnen bestudeerd. In een volgend project wordt met dierproeven het effect van de meest kansrijke eiwitbronnen op darmfunctie, -gezondheid en dierprestatie bestudeerd.
